Biomarkers, Vaccines and Personalized Medicine Hot Topics at 2010 BIO International Convention
“This year’s program showcases recent scientific advancements as well as the business and regulatory issues that allow our industry to extend and improve the health and lives of people around the globe,” said Jim Greenwood, BIO’s President and CEO. “The biotechnology community is constantly finding innovations that may someday treat or cure the most prevalent diseases, such as HIV/AIDS, cancer and malaria as well as numerous orphan diseases that affect smaller patient populations.”
The program includes historically popular tracks like Biomarkers and Drug Discovery and Development as well as new tracks for 2010 such as Delivery & Manufacturing of Biologics & Drugs, Global Drug Development and Marketing and Innovations in Vaccines.
A sample of breakout sessions includes:
· Therapeutic Cancer Vaccines – From Biological Complexity to Novel Patient Solutions
Monday, May 3, 2:00 p.m. – 3:30 p.m.
Speakers Include: Jens Oliver Funk, M.D., EMD Serono, Inc.; Wayne Godfrey
BN ImmunoTherapeutics, Inc.; Jeffrey Schlom, Ph.D., National Cancer Institute; Helen Sabzevari, National Cancer Institute; Mark Frohlich, M.D., Dendreon
· Commercialization of Biomarkers: From Discovery to Medical Diagnostics
Monday, May 3, 4:00 p.m. – 5:30 p.m.
Speakers include: Tim Clark, Piper Alderman; Christopher Boyle, Bio-Link; Michael Henry, Athena Diagnostics
· Build or Buy? Strategic Choices in Biomanufacturing
Tuesday, May 4, 2:00 p.m. – 3:30 p.m.
Speakers Include: Anne Montgomery, BioProcess International; Laura Bush, Advanstar Communications; Parrish Galliher, M.S., Xcellerex, Inc; Steven Lee, Ph.D., A-Bio Pharma Pte Ltd.; Alain Pralong, Crucell NV; Eric Langer, Ph.D., BioPlan Associates, Inc.
· Vaccines for the 21st Century
Tuesday, May 4, 2:00 p.m. – 3:30 p.m.
Speakers Include: Jeff Swarz, Ph.D., Caris and Company; Joe Shaw, Syntiron; Gavin Zealey, MBA, sanofi Pasteur; Vijay Samant, Ph.D.,Vical Inc.; Jan ter Meulen, M.D., Merck; James Jackson, Ph.D., Emergent BioSolutions, Inc.
· It’s Personal – Transforming Health Care through Personalized Medicine
Tuesday, May 4, 4:00 p.m. – 5:30 p.m.
Speakers Include: Edward Abrahams, Ph.D., Personalized Medicine Coalition; Linh Hoang, M.D., Life Technologies; Laura Shawver, Ph.D., The Clearity Foundation; Felix Frueh, MEDCO; Nicholas Dracapoli, Johnson & Johnson Pharmaceuticals
· Pandemic Preparedness: Therapeutics Policy and Deployment
Wednesday May 5, 10:00 a.m. – 11:30 a.m.
· FDA Town Hall
Wednesday, May 5, 10:00 a.m. – 11:30 a.m.
Speakers Include: Douglas Throckmorton, M.D., U.S. Food and Drug Administration, Center for Drug Evaluation and Research; Karen Midthun, MD, U.S. Food and Drug Administration, Center for Biologics Evaluation and Research
For detailed descriptions and a full program, please visit http://convention.bio.org/. Members of the media can register at http://convention.bio.org/media/.
The annual BIO International Convention helps to support the association’s programs and initiatives. BIO works throughout the year to create a policy environment that enables the industry to continue to fulfill its vision of bettering the world through biotechnology innovation.
Upcoming BIO Events
BIO Intellectual Property Counsels Spring Conference and Committee Meeting
April 19-21, 2010
New Orleans, LA
Partnering for Global Health
May 3, 2010
Chicago, IL
McCormick Place Convention Center
BIO International Convention
May 3-6, 2010
Chicago, IL
McCormick Place Convention Center
2010 BIO Human Resources Conference
May 4-7, 2010
Chicago, IL
World Congress on Industrial Biotechnology and Bioprocessing
June 27-30, 2010
Washington, DC
BIO India
September 21 - 22, 2010
Hyderabad, India
BIO’s Livestock Biotechnology Summit
September 28-30, 2010,
Sioux Falls, SD
About BIO
BIO represents more than 1,200 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the BIO International Convention, the world’s largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world.
###